UTHR
United Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$487.61
−0.54%Forward multiples
Based on analyst estimates
- P/E forward
- 18.85x
- P/E 2026E
- 18.72x
- P/E 2027E
- 16.94x
- P/E 2028E
- 14.12x
- P/S forward
- 6.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.13x
- PEG TTM
- 0.77x
- Price / book
- 3.27x
- Price / sales
- 6.63x
- Price / cash flow
- 12.41x
Enterprise value
- Enterprise value
- $18.3B
- EV / sales
- 5.79x
- EV / EBITDA
- 11.05x
- EV / EBIT
- 13.01x
- Market cap
- $20.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026